These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20424239)

  • 61. Editorial: Best Practices in Child Antipsychotic Use Monitoring.
    Hilt RJ
    J Am Acad Child Adolesc Psychiatry; 2021 Jan; 60(1):24-25. PubMed ID: 33176169
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preserving the lifesaving power of antimicrobial agents.
    Hughes JM
    JAMA; 2011 Mar; 305(10):1027-8. PubMed ID: 21343545
    [No Abstract]   [Full Text] [Related]  

  • 63. The evolving clinical profile of atypical antipsychotic medications.
    Buckley PF; Miller DD; Singer B; Donenwirth K
    Can J Psychiatry; 2001 Apr; 46(3):285. PubMed ID: 11320683
    [No Abstract]   [Full Text] [Related]  

  • 64. In Defense of Off-label Prescribing.
    Keller DL
    JAMA Intern Med; 2016 Jun; 176(6):861. PubMed ID: 27273485
    [No Abstract]   [Full Text] [Related]  

  • 65. Clozapine: is now the time for more clinicians to adopt this orphan?
    Stahl SM
    CNS Spectr; 2014 Aug; 19(4):279-81. PubMed ID: 25267329
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Psychiatric decision making in the adoption of a new antipsychotic in Germany.
    Hamann J; Adjan S; Leucht S; Kissling W
    Psychiatr Serv; 2006 May; 57(5):700-3. PubMed ID: 16675766
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Off-label paediatric drug use in an Indonesian community setting.
    Abdulah R; Khairinisa MA; Pratiwi AA; Barliana MI; Pradipta IS; Halimah E; Diantini A; Lestari K
    J Clin Pharm Ther; 2015 Aug; 40(4):409-12. PubMed ID: 25884353
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gender differences in the prescribing of antipsychotic drugs.
    Seeman MV
    Am J Psychiatry; 2004 Aug; 161(8):1324-33. PubMed ID: 15285956
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In Defense of Off-label Prescribing-Reply.
    Eguale T; Verma A; Tamblyn R
    JAMA Intern Med; 2016 Jun; 176(6):861-2. PubMed ID: 27273486
    [No Abstract]   [Full Text] [Related]  

  • 70. Screening for metabolic syndrome-adherence to guidelines.
    Marsay C; Szabo CP
    Afr J Psychiatry (Johannesbg); 2011 Mar; 14(1):64, 66. PubMed ID: 21509412
    [No Abstract]   [Full Text] [Related]  

  • 71. Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications.
    Paczynski RP; Alexander GC; Chinchilli VM; Kruszewski SP
    Int J Risk Saf Med; 2012 Jan; 24(3):137-46. PubMed ID: 22936056
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Challenges associated with treating and preventing antipsychotic-induced constipation: considerations and cautions when prescribing novel interventions.
    Demler TL; Krieger K
    Int Clin Psychopharmacol; 2021 Jan; 36(1):12-17. PubMed ID: 32897928
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of FDA safety warnings may vary.
    Kuehn BM
    JAMA; 2012 Mar; 307(9):894-5. PubMed ID: 22396504
    [No Abstract]   [Full Text] [Related]  

  • 74. Restricting physician prescribing.
    Somberg JC
    Am J Ther; 2002; 9(5):369. PubMed ID: 12237726
    [No Abstract]   [Full Text] [Related]  

  • 75. [The Medical Products Agency is positive to a dialogue about off-label prescribing].
    Babra A; Arlander E
    Lakartidningen; 2015 May; 112():. PubMed ID: 25988651
    [No Abstract]   [Full Text] [Related]  

  • 76. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
    Roehr B
    BMJ; 2012 Oct; 345():e6633. PubMed ID: 23033376
    [No Abstract]   [Full Text] [Related]  

  • 77. FDA tightens indications for using long-acting and extended-release opioids to treat chronic pain.
    Kuehn BM
    JAMA; 2013 Oct; 310(15):1547-8. PubMed ID: 24129447
    [No Abstract]   [Full Text] [Related]  

  • 78. Off-label prescribing of antidepressants.
    Morales DR; Guthrie B
    BMJ; 2017 Feb; 356():j849. PubMed ID: 28223288
    [No Abstract]   [Full Text] [Related]  

  • 79. MP for older people.
    Doherty L
    Nurs Older People; 2008 May; 20(4):7-8. PubMed ID: 18549106
    [No Abstract]   [Full Text] [Related]  

  • 80. Robust systems are needed for off-label prescribing.
    Ross S
    BMJ; 2017 Mar; 356():j1362. PubMed ID: 28314712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.